Suzanne Bowdey

And I know a lot of people have made statements on this, um, but I think we need to ponder them and think about them, and, uh, a- and, and I've developed, you know, or I've come to a conclusion on this, but we're gonna discuss it here, uh, unscripted.

Uh, joining me now to talk about this and more is our Washington Stand panel for today, Suzanne Bowdey, editorial director and senior writer at The Stand, and Kaycee Harper, The Stand's managing editor of broadcast.

Suzanne, Kaycee, thanks for joining me.

Thanks, Tony.

The FDA says after completing the study and review, it will decide whether to change its policies, which have paved the way for the trafficking of the abortion drug into states with pro-life laws, as well as a rise in the abortion numbers, almost a 20%, uh, actually, over a 20% increase in abortions since before the overturn of Roe.

Joining me now to talk about this and more is our Washington Stand panel for today, Suzanne Bowdey, editorial director and senior writer at The Stand, and Kaycee Harper, The Stand's medi- ma- managing editor of broadcast.

Suzanne and Kaycee, thanks for joining me.

Thanks, Tony.